Gene therapy outpaces haplo for SCID-X1

Blood

Volumn 125, Issue 23, 2015, Pages 3521-3522

  Kohn, Donald B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR GAMMA; PHYTOHEMAGGLUTININ; RETROVIRUS VECTOR;

AUTOTRANSPLANTATION; CD34 SELECTION; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL READMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRAL GENE THERAPY; X LINKED SEVERE COMBINED IMMUNODEFICIENCY; FEMALE; GENE THERAPY; IMMUNOLOGY; MALE; THYMUS; X-LINKED COMBINED IMMUNODEFICIENCY DISEASES;

FEMALE; GENETIC THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; MALE; T-LYMPHOCYTES; THYMUS GLAND; X-LINKED COMBINED IMMUNODEFICIENCY DISEASES;

EID: 84930665543     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-04-641720     Document Type: Note

References (8)

1. Touzot F, Moshous D, Creidy R, et al. Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1. Blood. 2015;125(23):3563-3569.
2. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288(5466):669-672.
3. Hacein-Bey-Abina S, Hauer J, Lim A, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2010;363(4):355-364.
4. Gaspar HB, Cooray S, Gilmour KC, et al. Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med. 2011;3(97):97ra79.
5. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302(5644):415-419.
6. Howe SJ, Mansour MR, Schwarzwaelder K, et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest. 2008;118(9):3143-3150.
7. Hacein-Bey-Abina S, Pai SY, Gaspar HB, et al. A modified g-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med. 2014;371(15):1407-1417.
8. Rossi DJ, Bryder D, Zahn JM, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA. 2005;102(26):9194-9199.